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`    Experimental design
1.   Sample size
Describe how sample size was determined. No sample size calculations were performed. The sample size (n) of each experiment is 
provided in the corresponding figure captions in the main manuscript and supplementary 
information files. Sample sizes were chosen to support meaningful conclusions. 
2.   Data exclusions
Describe any data exclusions. No data was excluded from the analyses.
3.   Replication
Describe the measures taken to verify the reproducibility 
of the experimental findings.
All in vitro experiments were replicated successfully 2 or 3 times. In vivo optical IOP 
measurements were conducted on one sensor of each type and were replicated successfully 
2 times while immunofluorescence microscopy on the retrieved sensors was conducted once.
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
In the reported experiments, each group consisted of identically engineered samples. The 
work does not involve participant groups. Therefore, randomization was not relevant the 
study. 
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
Methods for group allocation, data collection and all related analyses were predetermined. 
Furthermore, the work does not involve participant groups. Therefore, blinding was not 
relevant to the study. 
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
Test values indicating whether an effect is present 
Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
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`   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
COMSOL 5.3, ImageJ 1.51, Lumerical 8.19.1416, Matlab R2016b, Prism Graphpad 7.0d, Zeiss 
ZEN 2.1
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
`   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a third party.
No unique materials were used.
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
This work used Alexa Fluor 594 anti-MMP2 antibody, an anti-MMP2 antibody directly 
conjugated with the alexa fluor 594 dye (Cat.# 679904) at a 1:500 dilution. The dye was 
purchased from BioLegend Inc (San Diego, CA 92121), Clone # M6303D01, Lot #B212008  -  
"https://www.biolegend.com/de-de/products/alexa-fluor-594-anti-mmp2-antibody-12822". 
10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. The HeLa cells used in this work were purchased from ATCC.
b.  Describe the method of cell line authentication used. None of the cell lines have been authenticated.
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
The cell lines were not tested for mycoplasma contamination.
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used.
`    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide all relevant details on animals and/or 
animal-derived materials used in the study.
New Zealand white Rabbit, female, 2.5kg, 5 months old.
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
The study did not involve human research participants.
